Navigation Links
The Rossbacher Law Firm, Hagens Berman Sobol Shapiro LLP, Wilentz Goldman & Spitzer, P.A., Reed Smith LLP and Thompson Hine LLP, Announce the Proposed Settlement of a Class Action Lawsuit Concerning Estratest and Solvay Pharmaceuticals, Inc.

LOS ANGELES, Aug. 24 /PRNewswire/ -- The following statement is being issued by The Rossbacher Firm, Hagens Berman Sobol Shapiro LLP, Wilentz Goldman & Spitzer, P.A., Reed Smith LLP, and Thompson Hine LLP pursuant to an Order of the Superior Court of the State of California, for the County of Los Angeles, Central Civil West:

If You Made a Payment or Co-Payment For the Purchase of the Hormone Replacement Therapy Drugs Estratest or Estratest H.S. in California, You Could Benefit From A Class Action Settlement

Read This Notice and visit for a Claim Form

The Los Angeles County Superior Court has authorized this notice.

This is not a solicitation for a lawyer

Para una notificacion en espanol, visitar

California Only Case


Since August 2003, two class action lawsuits have been pending in California state court. The lawsuits, filed by individuals, have been brought on behalf of any person or Third Party Payor ("TPP") who paid any part of the cost of Estratest or Estratest H.S. (collectively referred to as "Estratest"), purchased in California at any time since August 7, 1999. The lawsuits exclude persons with pending claims against Solvay Pharmaceuticals, Inc. ("Solvay") for personal injury or wrongful death, and also exclude persons or TPP's who purchased Estratest for purposes of resale (the "Class"). Plaintiffs assert claims against Solvay for violations of California state unfair competition and false and deceptive advertising laws in connection with Solvay's marketing of Estratest. Solvay denies the claims asserted by plaintiffs and has denied that it engaged in unfair, false or deceptive marketing related to Estratest. Solvay further maintains that purchasers have not been injured and are not entitled to any monetary damages or other forms of relief. A California state court certified a California Class on May 1, 2008. The parties have agreed to a settlement of the litigation.


Estratest is a prescription hormone replacement therapy drug within a class of drugs prescribed for the treatment of moderate to severe vasomotor symptoms associated with menopause in patients whose symptoms are not relieved by estrogen alone.


Solvay has agreed to pay $30 million dollars into a Settlement Fund to pay refunds to purchasers of Estratest. The Settlement Fund will also be used to pay for the reasonable costs of notice to the California Class, the costs of claims administration, and reasonable attorneys' fees, expenses, and Plaintiff's incentive awards to be approved by the Court. Purchasers will be allowed to obtain refunds not to exceed 30% of the purchase price paid for Estratest. Funds remaining after disbursements, if any, will be distributed by cy pres per Court Order consistent with Cal. Code Civ. Proc. Section 384 and the Settlement Agreement. In order to obtain a refund, Class Members must timely submit a claim form stating their total out of pocket expenditures for Estratest during the Class period. The Settlement provides a release by Class Members of any current or future California non-personal injury claims against Solvay relating to Solvay's marketing, advertising and sale of Estratest, including representations about the regulatory status of Estratest. If the Court approves the settlement and it becomes final, the class action lawsuits will be dismissed, with prejudice, and Class Members will not be able to sue Solvay in the future based upon the same claims.


If you believe you are a member of the Class and wish to participate in the settlement you must submit a claim form to the Claims Administrator at the address listed below, postmarked on or before February 12, 2010. You may file a motion with the Court for permission to appear, intervene, and/or object, filed, served, and received on or before November 2, 2009. A Final Approval Hearing has been scheduled for December 2, 2009 at 10:00 a.m. at the Los Angeles County Superior Court, 600 South Commonwealth Avenue, Department CCW - 309, Los Angeles, CA 90005, at which time the Court will consider the adequacy and fairness of the settlement and any fee application. All motions to make an appearance, intervene and/or object at the Final Approval Hearing must be filed with the Court at the above address. Any documentation that you file with the Court must also be mailed on or before November 2, 2009 to Co-Lead Counsel for the Plaintiff Class - Henry H. Rossbacher, The Rossbacher Firm, 811 Wilshire Blvd., Suite 1650, Los Angeles, CA 90017 and Counsel for Defendant - David E. Stanley, Reed Smith LLP, 355 South Grand Ave., Suite 2900, Los Angeles CA 90017.


If you have questions about this Notice of the Settlement, wish to obtain additional information, or wish to request that a copy of the Notice and Claim Form be mailed to you, you should call 888-821-8161, visit the Settlement website address: or write to Estratest Settlement Litigation, c/o Gilardi & Co. LLC, P.O. Box 8060, San Rafael, CA 94912-8060. You may also seek advice and guidance from an attorney, at your own expense, if you so desire. This Notice is only a summary. For more detailed information you may review the Settlement Agreement which contains the complete terms of the Proposed Settlement. The Settlement Agreement is on file with the Clerk's Office of the Los Angeles Superior Court and is available to be inspected at the Clerk's Office at any time during regular business hours. The Settlement Agreement may also be viewed at the website addresses listed above. You may also review the pleadings, records, and other papers on file at the Clerk's Office. The Clerk of the Court for Los Angeles Superior Court is located at 600 South Commonwealth Avenue, Los Angeles, CA 90005.


Dated: August 11, 2009 The Honorable Anthony J. Mohr

SOURCE The Rossbacher Firm
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. MaxLife Fund Corp. retains the Law firm, Anslow & Jaclin, LLP of Manalapan, N.J., to review MaxLife Fund Corp. options to be listed on the NASDAQ Capital Market
2. Parker Waichman Alonso LLP, Becnel Law Firm, LLC, Douglas & London P.C., Levin
3. DrScore, the Premier Online Patient Satisfaction Service Partners With Leading Healthcare Web Design Firm, Practis, Inc.
4. Californian Files Contact Lens Solution False Advertising Class Action Against Advanced Medical Optics, Announces the Schmidt Firm, LLP
5. Rulings Send Lawsuits Against State Farm, American Family Back to Court, Hagens Berman Sobol Shapiro Announces
6. Hagens Berman Sobol Shapiro: Judge Orders Double Damages, Issues Stinging Rebuke in Average Wholesale Price Case
7. Hagens Berman Sobol Shapiro Announces Investigation Into Marketing of Vytorin and Zetia
8. CORRECTED: Hagens Berman Sobol Shapiro Files Suit Against Merck and Schering-Plough
9. Anatomist Dr. Gunther von Hagens Clarifies: Plastinates Not For Sale
10. Hagens Berman: Eleven Defendants Settle in Average Wholesale Price Litigation
11. Hagens Berman Sobol Shapiro: Nationwide Class Action Certified in Average Wholesale Price Litigation
Post Your Comments:
(Date:11/27/2015)... ... 2015 , ... MPWH, the No.1 Herpes-only dating community in the world, revealed that over 50% ... More than 3.7 billion people under the age of 50 – or 67% of the ... first global estimates of HSV-1 infection . , "The data shocks us highly!" said ...
(Date:11/27/2015)... DE (PRWEB) , ... November 27, 2015 , ... ... member of the well-respected Microsoft Dynamics SL User Group (MSDSLUG). Recognized as Microsoft’s ... an independent group of Microsoft Dynamics SL software users, partners, industry experts and ...
(Date:11/27/2015)... ... November 27, 2015 , ... The moment you stop ... not only fulfilling the needs of advisers and clients but going above and ... providing top-tier customer service. However, there's always room for improvement, which is why ...
(Date:11/27/2015)... ... ... CBD College is proud to announce that on November 20th, ... its Diagnostic Medical Sonography program. CBD College is honored to join this very short ... universities in the state of California make the cut. CBD College is officially the ...
(Date:11/27/2015)... , ... November 27, 2015 , ... Dr. Thomas ... Associates, Inc. and Dr. Tucker Bierbaum with Emergency Medicine at St., Joseph ... that both STEMI and Sepsis conditions present in similar ways and require time-critical intervention ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 2015 Research and Markets ( ... "2016 Future Horizons and Growth Strategies in the ... Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities" ... --> --> This new 247-page ... therapeutic drug monitoring market, including emerging tests, technologies, ...
(Date:11/26/2015)... 2015 --> ... potential att använda SyMRI för att hitta ... patienter med multipel skleros (MS) eller hjärntumörmetastaser ... AB för att kunna använda SyMRI Research ... SyMRI kan man generera flera konstrastbilder från ...
(Date:11/26/2015)... , November 26, 2015 ... the "Self Administration of High Viscosity Drugs" ... ) has announced the addition of the ... report to their offering. --> Research ... addition of the "Self Administration of High ...
Breaking Medicine Technology: